drugset / Trial / NCT00511797
SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate efficacy of drospirenone for dysmenorrhea.
Timeline
- Start
- 2007-07
- Primary completion
- 2009-01
- Completion
- 2009-01
Publications
- Results Momoeda M, et al. Treatment of Functional and Organic Dysmenorrhea - Investigation of the Efficacy and Safety of Drospirenone/Ethinylestradiol Combination Tablet (YAZ). Sanka to Fujinka (Obstetrics and Gynecology), 2010: 77 (8) 977-88 (in Japanese)
- Schroll JB, Black AY, Farquhar C, Chen I. Combined oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2023 Jul 31;7(7):CD002120. doi: 10.1002/14651858.CD002120.pub4.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | drospirenone | Unknown | 1 mg | Oral |
| Subject | drospirenone | Unknown | 2 mg | Oral |
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 20 ug | Oral |